1. Home
  2. PMNT vs CTXR Comparison

PMNT vs CTXR Comparison

Compare PMNT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMNT
  • CTXR
  • Stock Information
  • Founded
  • PMNT 1984
  • CTXR 2007
  • Country
  • PMNT United Kingdom
  • CTXR United States
  • Employees
  • PMNT N/A
  • CTXR N/A
  • Industry
  • PMNT
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMNT
  • CTXR Health Care
  • Exchange
  • PMNT NYSE
  • CTXR Nasdaq
  • Market Cap
  • PMNT 18.0M
  • CTXR 14.6M
  • IPO Year
  • PMNT 2024
  • CTXR N/A
  • Fundamental
  • Price
  • PMNT $0.86
  • CTXR $0.94
  • Analyst Decision
  • PMNT Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • PMNT 1
  • CTXR 2
  • Target Price
  • PMNT $6.00
  • CTXR $54.50
  • AVG Volume (30 Days)
  • PMNT 11.6K
  • CTXR 142.3K
  • Earning Date
  • PMNT 06-30-2025
  • CTXR 05-23-2025
  • Dividend Yield
  • PMNT N/A
  • CTXR N/A
  • EPS Growth
  • PMNT N/A
  • CTXR N/A
  • EPS
  • PMNT N/A
  • CTXR N/A
  • Revenue
  • PMNT $21,307,000.00
  • CTXR N/A
  • Revenue This Year
  • PMNT $3.91
  • CTXR N/A
  • Revenue Next Year
  • PMNT $29.32
  • CTXR N/A
  • P/E Ratio
  • PMNT N/A
  • CTXR N/A
  • Revenue Growth
  • PMNT N/A
  • CTXR N/A
  • 52 Week Low
  • PMNT $0.66
  • CTXR $0.68
  • 52 Week High
  • PMNT $3.08
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • PMNT N/A
  • CTXR 51.36
  • Support Level
  • PMNT N/A
  • CTXR $0.65
  • Resistance Level
  • PMNT N/A
  • CTXR $0.82
  • Average True Range (ATR)
  • PMNT 0.00
  • CTXR 0.09
  • MACD
  • PMNT 0.00
  • CTXR 0.04
  • Stochastic Oscillator
  • PMNT 0.00
  • CTXR 85.69

About PMNT PERFECT MOMENT LTD

Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: